# Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered

> **NCT03838783** · PHASE4 · UNKNOWN · sponsor: **LMC Diabetes & Endocrinology Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin Degludec

## Key facts

- **NCT ID:** NCT03838783
- **Lead sponsor:** LMC Diabetes & Endocrinology Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-15
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03838783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03838783, "Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03838783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*